Corpus Intelligence DCF — PARKVIEW - DEKALB HEALTH 2026-04-26 18:24 UTC
DCF — PARKVIEW - DEKALB HEALTH
Enterprise Value: $-90.6M
🛡️ Public data only — no PHI permitted on this instance.
$-90.6M
Enterprise Value
$-29.0M
PV of Cash Flows
$-61.6M
PV of Terminal Value
$-99.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth

Cash Flow Projections

PROJ
YearRevenueEBITDAMarginFCFPV(FCF)
Year 1$67.1M$-5.5M-8.0%$-8.3M$-7.5M
Year 2$69.1M$-4.9M-7.0%$-7.8M$-6.5M
Year 3$71.2M$-4.4M-6.0%$-7.4M$-5.5M
Year 4$73.3M$-4.1M-6.0%$-7.2M$-4.9M
Year 5$75.5M$-4.1M-5.0%$-7.3M$-4.5M

Interpretation

INT

At a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-90.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.

Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.

Assumptions

ASSM
revenue base$65.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08624047548201456
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5